August 29, 2017
ivWatch LLC, which offers continuous monitoring devices for the early detection of peripheral IV infiltrations, has been awarded an Innovative Technology contract from Vizient, Inc.
The device can help in early detection of peripheral IV infiltration and extravasation events.
The Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, Vizient said.
The ivWatch Model 400 continuously monitors a patient’s peripheral IV for evidence of infiltrations, which occur when medication or fluid leaks into the surrounding tissue.
Read the full article here.